Clinical Trials

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07445451 2026-03-03

TURBT

93 enrolled

Urinary Bladder Neoplasms, Pain, Postoperative

NCT06117059 2026-01-12

PRECISION

Prostatic Neoplasms

NCT07308990 2025-12-30

Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

800 enrolled

Prostatic Neoplasms

NCT01089387 2025-12-04

INSTIN

Phase 1/2 Completed

18 enrolled

Phase NA Active not recruiting

Erectile Dysfunction, Prostatic Neoplasms

NCT06238596 2025-10-03

ReCaP

38 enrolled

Phase NA Active not recruiting

Prostatic Neoplasms

NCT03814252 2025-09-22

PRO-TULSA-PC

62 enrolled

Localized Prostate Cancer

NCT06388720 2025-09-15

IMGeS

Phase 2 Recruiting

82 enrolled

Urinary Bladder Neoplasms

NCT03232541 2025-08-24

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

BreastGastrointestinalGenitourinary

198 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Vomiting, Colorectal Neoplasms

NCT07125924 2025-08-15

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

Phase NA Not yet recruiting

54 enrolled

GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms

NCT03093688 2025-07-02

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

40 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT02711202 2025-06-04

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

20 enrolled 11 charts

Kidney Transplantation

NCT06398314 2025-05-23

PALLSOFT

GastrointestinalGenitourinary

200 enrolled

Gastrointestinal Neoplasms, Urologic Neoplasms

NCT06915909 2025-04-08

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Phase NA Not yet recruiting

40 enrolled

Adenocarcinoma, Pain, Pain, Postoperative, Prostatic Neoplasms

NCT06565247 2025-03-04

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Phase 3 Recruiting

60 enrolled

Prostatic Neoplasms

NCT06766526 2025-02-24

ISAC

180 enrolled

Phase 1 Active not recruiting

Anxiety Disorders, Sleep Initiation and Maintenance Disorders, Neoplasms, Prostatic Neoplasms

NCT05917860 2025-02-17

NeoADT-TULSA

15 enrolled

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT06756334 2025-01-03

Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostatic Neoplasms

NCT03350529 2024-11-25

HIFU-PRO

87 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT04316520 2024-08-16

CETOREIN

20 enrolled

Phase EARLY_PHASE1 Recruiting

Kidney Neoplasms

NCT06462495 2024-06-17

Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT06462508 2024-06-17

Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostatic Neoplasms

NCT05046665 2024-04-22

ZiPUP

Phase 1 Completed

11 enrolled

Carcinoma, Transitional Cell

NCT05326282 2024-02-28

ERUP

Prostatic Neoplasms

NCT05587192 2024-02-12

RPWPB

57 enrolled

Disease, Prostatic Neoplasms

NCT06219746 2024-01-23

99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer

320 enrolled

Prostatic Neoplasms

NCT05063760 2023-12-05

ExCell

60 enrolled

Testicular Germ Cell Tumor

NCT06119438 2023-11-07

Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy

120 enrolled

Anxiety Disorders, Prostatic Neoplasms

NCT06001619 2023-08-21

PROMED

Phase 4 Recruiting

Phase EARLY_PHASE1 Unknown

Prostatic Hyperplasia, Prostatic Neoplasms

NCT05955677 2023-07-21

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Phase 2/3 Active not recruiting

Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

11,992 enrolled

Prostatic Neoplasms

NCT01675219 2023-04-13

Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)

Phase 3 Unknown

400 enrolled

Urinary Bladder Neoplasms, Recurrence

NCT03058757 2023-01-31

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

Phase 2 Completed

71 enrolled

Urinary Bladder Neoplasms

NCT05704231 2023-01-30

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

60 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence, Smoking, Disease Progression

NCT04500080 2022-10-19

PCa_Ex

5 enrolled

Motor Activity, Prostatic Neoplasms

NCT05493956 2022-09-09

RACE-GB

GastrointestinalGenitourinary

120 enrolled

Gallbladder Cancer Unresectable

NCT05427864 2022-06-28

Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging

47 enrolled

Prostatic Neoplasms

NCT03537391 2022-05-04

PROSTAGE

80 enrolled

Prostatic Neoplasms

NCT03062059 2022-04-14

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Phase 2 Unknown

134 enrolled

Carcinoma, Transitional Cell

NCT04287088 2021-11-23

multiIMPROD2

600 enrolled

Prostatic Neoplasms

NCT03876912 2021-04-13

ADTPSMA2

35 enrolled

Prostatic Neoplasms

NCT04834089 2021-04-08

SOROCOV

Phase 1/2 Unknown

618 enrolled

COVID-19, Cardiovascular Diseases, Diabetes Mellitus, Kidney Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Phase 1 Unknown

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT02860819 2021-03-03

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

Phase 2 Completed

15 enrolled

Testicular Neoplasms

NCT04383067 2021-02-11

A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients

Phase 2 Unknown

20 enrolled

Carcinoma, Transitional Cell

NCT04184232 2021-01-22

Treatment of Recurrent Bladder Cancer With Dendritic Cells

Phase 2 Completed

17 enrolled

Urinary Bladder Neoplasms

NCT04523896 2020-08-24

BRAchySABR

Phase 2 Unknown

50 enrolled

Prostatic Neoplasms

NCT02662166 2020-06-17

MIB

50 enrolled

Urinary Bladder Neoplasms

NCT04064047 2020-01-13

Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy

284 enrolled